Publisher's Synopsis
Offering developments in pharmacology of anti-cancer agents, the area of biologicals and clinical management of the cancer patient, this study discusses the introduction of taxol, taxotere, gemcitabine, the topo 1 inhibitor, CTp-11 and TS such as tomudex.